A detailed history of Caption Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Caption Management, LLC holds 25,000 shares of BNTX stock, worth $2.87 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
25,000
Holding current value
$2.87 Million
% of portfolio
0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$98.5 - $125.08 $975,150 - $1.24 Million
9,900 New
9,900 $1.08 Million
Q1 2022

May 13, 2022

SELL
$126.25 - $231.85 $277,750 - $510,070
-2,200 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$216.64 - $362.52 $433,280 - $725,040
2,000 Added 1000.0%
2,200 $568,000
Q3 2021

Nov 12, 2021

SELL
$205.93 - $447.23 $3.42 Million - $7.42 Million
-16,600 Reduced 98.81%
200 $55,000
Q2 2020

Aug 14, 2020

BUY
$38.58 - $66.74 $648,144 - $1.12 Million
16,800 New
16,800 $1.12 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.9B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.